The ovarian carcinoma samples were divided into two groups based on the relative expression levels of the AMPK subunits, that is, greater than or smaller than/equal to two-folds of the mean of the relative expression levels of the normal samples. Here, PRKAA2 is linked to ovarian carcinoma.